0001562180-19-002643.txt : 20190506
0001562180-19-002643.hdr.sgml : 20190506
20190506182137
ACCESSION NUMBER: 0001562180-19-002643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190506
FILED AS OF DATE: 20190506
DATE AS OF CHANGE: 20190506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FRATES JAMES M
CENTRAL INDEX KEY: 0001235598
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 19800714
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 021394136
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-05-06
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001235598
FRATES JAMES M
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
true
false
false
false
Common Stock
2019-05-06
4
M
false
8000.00
8.92
A
12235.00
D
Common Stock
2019-05-06
4
S
false
8000.00
162.22
D
4235.00
D
Stock Option (Right to Buy)
8.92
2019-05-06
4
M
false
8000.00
0.00
D
2024-05-21
Common Stock
8000.00
1309.00
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The shares subject to the option vested 33% on the first anniversary of the grant date and quarterly thereafter, such that 100% of the shares subject to the option were fully vested and exercisable on May 26, 2017.
/s/ Anne Marie Cook, as Attorney-in-Fact for James M. Frates
2019-05-06